查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1889487

2025年全球體外感染疾病診斷市場報告

Infectious Disease In Vitro Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，感染疾病體外診斷市場經歷了顯著成長，預計將從2024年的141.4億美元成長到2025年的151億美元，複合年成長率為6.7%。過去幾年成長要素包括抗生素抗藥性、全球化和旅行的增加、人口老化、新病原體的出現以及生物恐怖主義的威脅。

預計未來幾年，感染疾病體外診斷市場將強勁成長，到2029年市場規模將達到198.3億美元，複合年成長率（CAGR）為7.0%。預測期內的成長可歸因於就地檢驗（POC​​T）需求的不斷成長、感染疾病流行率的上升、個人化醫療的日益普及以及新興市場醫療基礎設施的不斷完善。預測期間的關鍵趨勢包括下一代定序、微流體控平台、實驗室晶片技術、多重聚合酵素鏈鎖反應（PCR）檢測和數位免疫檢測。

過去，全球感染疾病的增加推動了感染疾病體外診斷市場的成長。感染疾病指在特定時期影響全球人口的細菌、病毒、真菌或寄生蟲感染疾病，反映了整體疾病負擔。氣候變遷擴大了蚊子等病媒的棲息地，加劇了全球感染疾病的流行。感染疾病體外診斷透過提供準確快速的診斷工具，幫助醫療專業人員檢測病原體、啟動適當的治療並有效控制疫情，從而支持了這一趨勢。例如，根據世界衛生組織（世衛組織）2024年10月發布的報告，全球約有1,080萬人將感染結核病，其中男性佔55%，女性佔33%，兒童12%，愛滋病毒感染者佔6.1%。因此，全球感染疾病流行率的上升促進了過去一段時間內感染疾病體外診斷市場的發展。

感染疾病體外診斷市場的主要企業正在開發創新產品，例如快速檢測多種胃腸道病原體，以實現更快的診斷、改善患者預後並擴大就地檢驗。快速檢測多種胃腸道病原體是指從單一檢體中快速識別胃腸道中多種致病微生物的診斷測試。 2024年6月，總部位於美國的MP Biomedicals公司（提供產品、化學品和診斷試劑的供應商）推出了用於胃腸道感染疾病的層析法快速診斷試劑盒。這些試劑盒能夠快速且準確地檢測幽門螺旋桿菌、傷寒沙門氏菌以及霍亂弧菌O1和O139血清型。這些試劑盒支援在照護現場進行快速定性檢測，並且相容於多種檢體，包括糞便、血液、血漿、血清、水和食物。層析法技術適用於臨床和研究環境，可用於早期診斷、治療進展監測和病原體清除確認。本文介紹了一種兼具速度快、準確性高和病原體檢測範圍廣的解決方案。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球感染疾病體外診斷市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 終端用戶產業分析
  • 全球感染疾病體外診斷市場：成長率分析
  • 全球感染疾病體外診斷市場表現：規模與成長，2019-2024年
  • 全球感染疾病體外診斷市場預測：規模與成長，2024-2029年，2034年
  • 全球感染疾病體外診斷市場：潛在市場規模 (TAM)

第6章 市場細分

  • 全球感染疾病體外診斷市場依產品類型、效能及預測分類，2019-2024年、2024-2029年、2034年
  • 裝置
  • 試劑
  • 軟體和服務
  • 全球感染疾病體外診斷市場：依技術、效能及預測分類，2019-2024年、2024-2029年、2034年
  • 分子診斷
  • 免疫檢測
  • 微生物學
  • 血液學
  • 尿液檢查
  • 其他
  • 全球感染疾病體外診斷市場依應用、效能及預測分類，2019-2024年、2024-2029年、2034年
  • 抗藥性金黃色葡萄球菌（MRSA）
  • 困難梭狀芽孢桿菌
  • 呼吸道病毒
  • 結核病（TB）和抗藥性結核病
  • 淋病
  • 人類乳突病毒（HPV）
  • 人類免疫力缺乏病毒（HIV）
  • C型肝炎
  • B型肝炎
  • 其他
  • 全球感染疾病體外診斷市場依最終用途、效能及預測分類，2019-2024年、2024-2029年、2034年
  • 醫院和診所
  • 診斷實驗室
  • 學術研究機構
  • 其他
  • 全球感染疾病體外診斷市場：設備細分、類型、性能和預測（2019-2024年、2024-2029年、2034年）
  • 聚合酵素鏈鎖反應裝置
  • 免疫檢測分析儀
  • 微生物分析儀
  • 血液分析儀
  • 尿液分析儀
  • 次世代定序儀
  • 流式細胞儀
  • 全球感染疾病體外診斷市場：試劑細分、類型、效能及預測（2019-2024年、2024-2029年、2034年）
  • 分子試劑
  • 免疫檢測試劑
  • 微生物試劑
  • 血液學試劑
  • 尿液檢查試劑
  • 酵素和緩衝液
  • 控制器和校準器
  • 全球感染疾病體外診斷市場：軟體和服務細分，按類型分類，實際結果和預測，2019-2024年、2024-2029年、2034年
  • 資料管理軟體
  • 檢查室資訊系統
  • 雲端基礎的解決方案
  • 維護支援服務
  • 諮詢和培訓服務
  • 遠端監控服務

第7章 區域和國家分析

  • 全球感染疾病體外診斷市場：依地區、績效及預測分類，2019-2024年、2024-2029年、2034年
  • 全球感染疾病體外診斷市場：國家、績效及預測，2019-2024年、2024-2029年、2034年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 體外感染疾病診斷市場：競爭格局
  • 感染疾病體外診斷市場：公司概況
    • F. Hoffmann-La Roche AG
    • Abbott Laboratories
    • Danaher Corporation
    • Thermo Fisher Scientific Inc.
    • Siemens Healthcare AG

第31章：其他領先和創新企業

  • BioMerieux SA
  • Qiagen NV
  • Becton
  • Dickinson and Company
  • Hologic Inc.
  • Labcorp Holdings Inc.
  • DiaSorin SpA
  • Meridian Bioscience
  • Quidel Corporation
  • Quest Diagnostics
  • Revvity 公司（前身為 PerkinElmer 公司）
  • OraSure Technologies Inc.
  • Transasia Bio-Medicals Ltd.
  • Randox Laboratories
  • Luminex Corporation

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：具有高市場潛力的國家及其策略

  • 2029年感染疾病體外診斷市場：提供新機會的國家
  • 2029年感染疾病體外診斷市場：提供新機會的細分市場
  • 2029年感染疾病體外診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r40035

Infectious disease in vitro diagnostics are laboratory tests performed on samples such as blood, urine, or swabs to detect, identify, and monitor infectious pathogens including bacteria, viruses, fungi, and parasites. These diagnostics enable accurate and timely diagnosis, guide treatment decisions, and support disease surveillance and infection control.

The main product types in infectious disease in vitro diagnostics are instruments, reagents, and software and services. Instruments are tools or devices used to measure and monitor environmental conditions including air, water, soil, and noise. They utilize technologies such as molecular diagnostics, immunoassay, microbiology, hematology, urinalysis, and others. Applications include methicillin-resistant Staphylococcus aureus, Clostridium difficile, respiratory viruses, tuberculosis and drug-resistant tuberculosis, gonorrhea, human papillomavirus, human immunodeficiency virus, hepatitis C, hepatitis B, and more. End-users include hospitals, clinics, diagnostic laboratories, academic research institutes, and other organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The infectious disease in vitro diagnostics market research report is one of a series of new reports from The Business Research Company that provides infectious disease in vitro diagnostics market statistics, including infectious disease in vitro diagnostics industry global market size, regional shares, competitors with an infectious disease in vitro diagnostics market share, detailed infectious disease in vitro diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the infectious disease in vitro diagnostics industry. This infectious disease in vitro diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The infectious disease in vitro diagnostics market size has grown strongly in recent years. It will grow from $14.14 billion in 2024 to $15.1 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth during the historic period is attributed to antibiotic resistance, globalization and travel, an aging population, the emergence of novel pathogens, and bioterrorism threats.

The infectious disease in vitro diagnostics market size is expected to see strong growth in the next few years. It will grow to $19.83 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to increasing demand for point-of-care testing, rising prevalence of infectious diseases, growing adoption of personalized medicine, and expansion of healthcare infrastructure in emerging markets. Key trends in the forecast period include next-generation sequencing, microfluidics-based platforms, lab-on-a-chip technology, multiplex polymerase chain reaction (PCR) assays, and digital immunoassays.

The rise in global infectious diseases drove the growth of the infectious disease in vitro diagnostics market during the historic period. Infectious diseases encompass bacterial, viral, fungal, or parasitic infections affecting populations worldwide at a given time, reflecting the overall disease burden. Changes in climate have expanded the habitats of vectors such as mosquitoes, increasing the global prevalence of infectious diseases. Infectious disease in vitro diagnostics support this trend by offering precise and timely diagnostic tools that allow healthcare providers to detect pathogens, initiate appropriate treatment, and control outbreaks efficiently. For example, in October 2024, the World Health Organization reported that approximately 10.8 million people worldwide contracted tuberculosis, with 55 percent men, 33 percent women, 12 percent children and adolescents, and 6.1 percent of cases among individuals living with HIV. Therefore, the rising global prevalence of infectious diseases contributed to the growth of the infectious disease in vitro diagnostics market during the historic period.

Major companies in the infectious disease in vitro diagnostics market are developing innovative products such as rapid detection of multiple gastrointestinal pathogens to enable timely diagnosis, improve patient outcomes, and expand point-of-care testing. Rapid detection of multiple gastrointestinal pathogens involves diagnostic tests that quickly identify several disease-causing microorganisms in the gastrointestinal tract from a single sample. In June 2024, MP Biomedicals, a US-based provider of products, chemicals, and diagnostics, launched immunochromatographic rapid diagnostic kits for gastrointestinal infectious diseases. These kits allow fast and accurate detection of Helicobacter pylori, Salmonella typhi, and Vibrio cholerae serogroups O1 and O139. They support rapid, point-of-care qualitative detection, versatile sample use including stool, blood, plasma, serum, water, and food, and are suitable for both clinical and research settings. Using immunochromatographic technology, they support early diagnosis, treatment monitoring, and confirmation of pathogen eradication, offering a combination of speed, precision, and broad pathogen coverage.

In January 2025, Fremman Capital, a UK-based private equity firm focused on healthcare and life sciences investments, acquired a majority stake in DIESSE Diagnostica Senese for an undisclosed sum. Fremman Capital intends to accelerate DIESSE's international growth and reinforce its position in the specialty in vitro diagnostics market by supporting innovation, expanding the product range for autoimmune and infectious disease diagnostics, and increasing production capacity at DIESSE's biotech campus, driving long-term sustainable growth. DIESSE Diagnostica Senese is an Italy-based developer of innovative in vitro diagnostics and reagents for autoimmunity, infectious diseases, and hematological testing, serving clinical laboratories worldwide.

Major companies operating in the infectious disease in vitro diagnostics market are F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation, Thermo Fisher Scientific Inc., Siemens Healthcare AG, BioMerieux SA, Qiagen N.V., Becton, Dickinson and Company, Hologic, Inc., Labcorp Holdings Inc., DiaSorin S.p.A., Meridian Bioscience, Quidel Corporation, Quest Diagnostics, Revvity Inc. (Formerly PerkinElmer, Inc.), OraSure Technologies, Inc., Transasia Bio-Medicals Ltd., Randox Laboratories, Luminex Corporation, Wako Pure Chemical Industries, Bio-Rad Laboratories Inc., Trivitron Healthcare, and InBios International Inc.

North America was the largest region in the infectious disease in vitro diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease in vitro diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the infectious disease in vitro diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The infectious disease in vitro diagnostics market consists of revenues earned by entities by providing services such as serology testing, rapid diagnostic testing, disease surveillance and monitoring, sample collection and processing, and consulting and training services. The market value includes the value of related goods sold by the service provider or included within the service offering. The infectious disease in vitro diagnostics market also includes sales of rapid test kits, culture media, controls and calibrators, molecular sequencing kits, flow cytometry reagents, and point-of-care diagnostic devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Infectious Disease In Vitro Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on infectious disease in vitro diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for infectious disease in vitro diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The infectious disease in vitro diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Instruments; Reagents; Software And Services
  • 2) By Technology: Molecular Diagnostics; Immunoassay; Microbiology; Hematology; Urinalysis; Other Technologies
  • 3) By Application: Methicillin-Resistant Staphylococcus Aureus (MRSA); Clostridium Difficile; Respiratory Virus; Tuberculosis (TB) And Drug-Resistant Tuberculosis (TB); Gonorrhea; Human Papillomavirus (HPV); Human Immunodeficiency Virus (HIV); Hepatitis C; Hepatitis B; Other Applications
  • 4) By End-Use: Hospitals And Clinics; Diagnostic Laboratories; Academic Research Institutes; Other End-Users
  • Subsegments:
  • 1) By Instrument: Polymerase Chain Reaction Machines; Immunoassay Analyzers; Microbiology Analyzers; Hematology Analyzers; Urinalysis Analyzers; Next Generation Sequencers; Flow Cytometers
  • 2) By Reagent: Molecular Reagents; Immunoassay Reagents; Microbiology Reagents; Hematology Reagents; Urinalysis Reagents; Enzymes And Buffers; Controls And Calibrators
  • 3) By Software And Services: Data Management Software; Laboratory Information Systems; Cloud Based Solutions; Maintenance And Support Services; Consulting And Training Services; Remote Monitoring Services
  • Companies Mentioned: F. Hoffmann-La Roche AG; Abbott Laboratories; Danaher Corporation; Thermo Fisher Scientific Inc.; Siemens Healthcare AG; BioMerieux SA; Qiagen N.V.; Becton; Dickinson and Company; Hologic; Inc.; Labcorp Holdings Inc.; DiaSorin S.p.A.; Meridian Bioscience; Quidel Corporation; Quest Diagnostics; Revvity Inc. (Formerly PerkinElmer; Inc.); OraSure Technologies; Inc.; Transasia Bio-Medicals Ltd.; Randox Laboratories; Luminex Corporation; Wako Pure Chemical Industries; Bio-Rad Laboratories Inc.; Trivitron Healthcare; and InBios International Inc.
  • Countries:

Table of Contents

1. Executive Summary

2. Infectious Disease In Vitro Diagnostics Market Characteristics

3. Infectious Disease In Vitro Diagnostics Market Trends And Strategies

4. Infectious Disease In Vitro Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Infectious Disease In Vitro Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Infectious Disease In Vitro Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Infectious Disease In Vitro Diagnostics Market Growth Rate Analysis
  • 5.4. Global Infectious Disease In Vitro Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Infectious Disease In Vitro Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Infectious Disease In Vitro Diagnostics Total Addressable Market (TAM)

6. Infectious Disease In Vitro Diagnostics Market Segmentation

  • 6.1. Global Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Reagents
  • Software And Services
  • 6.2. Global Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Diagnostics
  • Immunoassay
  • Microbiology
  • Hematology
  • Urinalysis
  • Other Technologies
  • 6.3. Global Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Methicillin-Resistant Staphylococcus Aureus (MRSA)
  • Clostridium Difficile
  • Respiratory Virus
  • Tuberculosis (TB) And Drug-Resistant Tuberculosis (TB)
  • Gonorrhea
  • Human Papillomavirus (HPV)
  • Human Immunodeficiency Virus (HIV)
  • Hepatitis C
  • Hepatitis B
  • Other Applications
  • 6.4. Global Infectious Disease In Vitro Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Academic Research Institutes
  • Other End-Users
  • 6.5. Global Infectious Disease In Vitro Diagnostics Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction Machines
  • Immunoassay Analyzers
  • Microbiology Analyzers
  • Hematology Analyzers
  • Urinalysis Analyzers
  • Next Generation Sequencers
  • Flow Cytometers
  • 6.6. Global Infectious Disease In Vitro Diagnostics Market, Sub-Segmentation Of Reagent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Reagents
  • Immunoassay Reagents
  • Microbiology Reagents
  • Hematology Reagents
  • Urinalysis Reagents
  • Enzymes And Buffers
  • Controls And Calibrators
  • 6.7. Global Infectious Disease In Vitro Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Management Software
  • Laboratory Information Systems
  • Cloud Based Solutions
  • Maintenance And Support Services
  • Consulting And Training Services
  • Remote Monitoring Services

7. Infectious Disease In Vitro Diagnostics Market Regional And Country Analysis

  • 7.1. Global Infectious Disease In Vitro Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Infectious Disease In Vitro Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Infectious Disease In Vitro Diagnostics Market

  • 8.1. Asia-Pacific Infectious Disease In Vitro Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Infectious Disease In Vitro Diagnostics Market

  • 9.1. China Infectious Disease In Vitro Diagnostics Market Overview
  • 9.2. China Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Infectious Disease In Vitro Diagnostics Market

  • 10.1. India Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Infectious Disease In Vitro Diagnostics Market

  • 11.1. Japan Infectious Disease In Vitro Diagnostics Market Overview
  • 11.2. Japan Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Infectious Disease In Vitro Diagnostics Market

  • 12.1. Australia Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Infectious Disease In Vitro Diagnostics Market

  • 13.1. Indonesia Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Infectious Disease In Vitro Diagnostics Market

  • 14.1. South Korea Infectious Disease In Vitro Diagnostics Market Overview
  • 14.2. South Korea Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Infectious Disease In Vitro Diagnostics Market

  • 15.1. Western Europe Infectious Disease In Vitro Diagnostics Market Overview
  • 15.2. Western Europe Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Infectious Disease In Vitro Diagnostics Market

  • 16.1. UK Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Infectious Disease In Vitro Diagnostics Market

  • 17.1. Germany Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Infectious Disease In Vitro Diagnostics Market

  • 18.1. France Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Infectious Disease In Vitro Diagnostics Market

  • 19.1. Italy Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Infectious Disease In Vitro Diagnostics Market

  • 20.1. Spain Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Infectious Disease In Vitro Diagnostics Market

  • 21.1. Eastern Europe Infectious Disease In Vitro Diagnostics Market Overview
  • 21.2. Eastern Europe Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Infectious Disease In Vitro Diagnostics Market

  • 22.1. Russia Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Infectious Disease In Vitro Diagnostics Market

  • 23.1. North America Infectious Disease In Vitro Diagnostics Market Overview
  • 23.2. North America Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Infectious Disease In Vitro Diagnostics Market

  • 24.1. USA Infectious Disease In Vitro Diagnostics Market Overview
  • 24.2. USA Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Infectious Disease In Vitro Diagnostics Market

  • 25.1. Canada Infectious Disease In Vitro Diagnostics Market Overview
  • 25.2. Canada Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Infectious Disease In Vitro Diagnostics Market

  • 26.1. South America Infectious Disease In Vitro Diagnostics Market Overview
  • 26.2. South America Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Infectious Disease In Vitro Diagnostics Market

  • 27.1. Brazil Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Infectious Disease In Vitro Diagnostics Market

  • 28.1. Middle East Infectious Disease In Vitro Diagnostics Market Overview
  • 28.2. Middle East Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Infectious Disease In Vitro Diagnostics Market

  • 29.1. Africa Infectious Disease In Vitro Diagnostics Market Overview
  • 29.2. Africa Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Infectious Disease In Vitro Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Infectious Disease In Vitro Diagnostics Market Competitive Landscape
  • 30.2. Infectious Disease In Vitro Diagnostics Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthcare AG Overview, Products and Services, Strategy and Financial Analysis

31. Infectious Disease In Vitro Diagnostics Market Other Major And Innovative Companies

  • 31.1. BioMerieux SA
  • 31.2. Qiagen N.V.
  • 31.3. Becton
  • 31.4. Dickinson and Company
  • 31.5. Hologic Inc.
  • 31.6. Labcorp Holdings Inc.
  • 31.7. DiaSorin S.p.A.
  • 31.8. Meridian Bioscience
  • 31.9. Quidel Corporation
  • 31.10. Quest Diagnostics
  • 31.11. Revvity Inc. (Formerly PerkinElmer Inc.)
  • 31.12. OraSure Technologies Inc.
  • 31.13. Transasia Bio-Medicals Ltd.
  • 31.14. Randox Laboratories
  • 31.15. Luminex Corporation

32. Global Infectious Disease In Vitro Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Infectious Disease In Vitro Diagnostics Market

34. Recent Developments In The Infectious Disease In Vitro Diagnostics Market

35. Infectious Disease In Vitro Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Infectious Disease In Vitro Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Infectious Disease In Vitro Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Infectious Disease In Vitro Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer